ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

XXII 22nd Century Group Inc

4.03
0.00 (0.00%)
Pre Market
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
22nd Century Group Inc AMEX:XXII AMEX Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.03 0 01:00:00

22nd Century to Present at SNN Network Investor Conference on August 19

17/08/2021 2:20pm

GlobeNewswire Inc.


22nd Century (AMEX:XXII)
Historical Stock Chart


From Jul 2021 to Jul 2024

Click Here for more 22nd Century Charts.

22nd Century Group, Inc. (Nasdaq: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced that its Chief Executive Officer, James A. Mish, is scheduled to present at the SNN Network Summer Virtual Event investor conference on Thursday, August 19, 2021 at 2:30 p.m. ET.

The presentation will be webcast live from the Company’s Investor Relations website under the Events subtab at: www.xxiicentury.com/investors/events.

Institutional investors and those invited to attend the virtual conference event may request one-on-one meetings with representatives of the Company through the SNN conference website or by contacting 22nd Century Group’s investor relations via investorrelations@xxiicentury.com.

About 22nd Century Group, Inc.22nd Century Group, Inc. (Nasdaq: XXII) is a leading plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene-editing, and modern plant breeding. 22nd Century’s primary mission in tobacco is to reduce the harm caused by smoking through the Company’s reduced nicotine content tobacco cigarettes – containing 95% less nicotine than conventional cigarettes. The Company’s primary mission in hemp/cannabis is to develop and commercialize proprietary hemp/cannabis plants with valuable cannabinoid profiles and desirable agronomic traits.

Learn more at xxiicentury.com, on Twitter @_xxiicentury, and on LinkedIn.

Cautionary Note Regarding Forward-Looking StatementsExcept for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements. Forward-looking statements typically contain terms such as “anticipate,” “believe,” “consider,” “continue,” “could,” “estimate,” “expect,” “explore,” “foresee,” “goal,” “guidance,” “intend,” “likely,” “may,” “plan,” “potential,” “predict,” “preliminary,” “probable,” “project,” “promising,” “seek,” “should,” “will,” “would,” and similar expressions. Actual results might differ materially from those explicit or implicit in forward-looking statements. Important factors that could cause actual results to differ materially are set forth in “Risk Factors” in the Company’s Annual Report on Form 10-K filed on March 11, 2021. All information provided in this release is as of the date hereof, and the Company assumes no obligation to and does not intend to update these forward-looking statements, except as required by law.

Investor Relations & Media Contact:Mei KuoDirector, Communications & Investor Relations22nd Century Group, Inc.(716) 300-1221mkuo@xxiicentury.com

 

1 Year 22nd Century Chart

1 Year 22nd Century Chart

1 Month 22nd Century Chart

1 Month 22nd Century Chart

Your Recent History

Delayed Upgrade Clock